10/03/2024
3:12 PM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
9:04 AM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:47 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:23 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:08 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
10:47 AM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
8:52 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/01/2024
3:17 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
2:34 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
2:25 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
3:06 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:05 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
11:27 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
12:16 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
9:27 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
9:23 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024
3:09 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:11 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
8:54 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
8:56 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:11 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:09 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
12:56 PM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:38 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
9:50 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
10:48 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:08 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
9:05 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
9:51 AM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
12:13 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
3:21 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
12:45 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
2:32 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
7:36 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
7:25 AM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/15/2024
11:20 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
10:41 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
10:50 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2024
7:01 AM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/08/2024
7:54 AM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/03/2024
3:05 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon Musk’s chilling warning for humanity (Ad) The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life. Go here to see why. |
05/02/2024
9:07 AM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2024
3:15 PM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T | |
04/16/2024
3:56 PM | Arjuna Capital (Filed by)
Vertex Pharmaceuticals (Subject)
| Form PX14A6G | |
04/11/2024
3:08 PM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/11/2024
6:13 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
6:17 AM | Vertex Pharmaceuticals (Subject)
| Form SC TO-C | |
04/10/2024
4:22 PM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/10/2024
11:14 AM | Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/04/2024
3:05 PM | Vertex Pharmaceuticals (Filer)
| Form ARS | |
02/27/2024
3:44 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:37 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:24 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
12:19 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
10:25 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
10:10 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
9:44 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
9:52 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
9:26 AM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:28 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:16 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:43 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:49 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:38 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:26 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:29 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
10:38 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
9:44 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
9:52 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
9:16 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:50 AM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:43 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
10:03 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
10:29 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:57 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:32 AM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:22 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:22 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
10:19 AM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
4:11 PM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
4:34 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:23 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
12:42 PM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
12:24 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
11:44 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
10:32 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
9:32 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
8:52 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
5:19 PM | Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
3:38 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Next opportunity for crypto millions (Ad) As October unfolds and the effects of the Fed Pivot ripple through the market, this crypto could skyrocket.
Want to know more? Click here to discover the altcoin set to dominate October's bull run. |
02/08/2024
3:40 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:43 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:45 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:47 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:20 PM | Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:10 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:09 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
3:06 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:56 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
